Medical Bulletin 27/ July/ 2024 Anshika Mishra27 July 2024 3:00 PM ISTHere are the top medical news for the day:New Autism Therapy Shows Promise in Enhancing Cognitive Abilities: study findsAccording to a recent study,...
New Study Highlights Fatty Liver Disease Risk in Spinal Muscular Atrophy Patients Anshika Mishra27 July 2024 8:45 AM ISTIn a study published in the prestigious Journal of Clinical Investigation, researchers have discovered that individuals with Spinal Muscular Atrophy...
Apitegromab improves motor function of patients with spinal muscular atrophy, reveals study Jacinthlyn Sylvia25 Feb 2024 11:45 PM ISTSpinal muscular atrophy (SMA) is a debilitating genetic disorder characterized by muscle weakness and degeneration that often leading to severe...
Voyager Therapeutics enters Capsid license agreement with Novartis to advance novel gene therapies Ruchika Sharma3 Jan 2024 2:37 PM ISTUnder the terms of the agreement, Novartis has agreed to pay Voyager $100 million of consideration up front, including a $20 million purchase of newly...
Early Pharmacological Treatment of Type II SMA Patients Slows Scoliosis Progression Dr Riya Dave19 Dec 2023 8:00 PM ISTA recent study has shed new light on the potential impact of early pharmacological interventions on scoliosis progression in individuals with Type II...
Health Bulletin 09/November/2023 Roshni Dhar9 Nov 2023 4:32 PM ISTHere are the top health stories for the day:Australian woman passed away after using OzempicA 56-year-old Australian woman named Trish Webster passed...
Royalty Pharma to pay USD 1 billion for Roche SMA drug royalties Ruchika Sharma22 Oct 2023 10:00 AM ISTPTC said it plans to use the proceeds from the deal to pay back its debt from Blackstone Life Sciences and to fund planned operations.
Insud Pharma inaugrates Oligonucleotides Centre in India Ruchika Sharma17 Sept 2023 1:00 PM ISTThis new plant will be capable of producing a novel antisense Oligonucleotide for the treatment of Spinal Muscular Atrophy.
Roche Evrysdi gets CHMP recommendation for babies under two months old with spinal muscular atrophy Ruchika Sharma24 July 2023 3:30 PM ISTEvrysdi is currently approved in the EU for the treatment of patients aged two months or older,
Kerala: Doctors at MCH perform spine surgery on 14-year-old SMA patient Kajal Rajput29 May 2023 1:00 PM ISTThiruvananthapuram: In a relief for Spinal Muscular Atrophy patients, a government medical college in Kerala has launched an innovative surgery to...
EMA seeks to issue guidance on liver damage from Novartis gene therapy Zolgensma Ruchika Sharma15 Jan 2023 12:15 PM ISTThe drug won conditional EU approval during early 2020 and it costs more than $2 million per patient
Zolgensma gene therapy caused two fatalities from liver failure, reports Novartis Ruchika Sharma14 Aug 2022 2:00 PM ISTBasel: Novartis AG on Thursday reported two patient fatalities due to acute liver failure following treatment with Zolgensma gene therapy used to...
